Key result
Cardiovascular implantable electronic devices complement medical treatment to improve survival, functional capacity, and quality of life in patients with chronic heart failure.
Why the study?
Chronic heart failure remains a major cause of morbidity and mortality despite guideline-directed medical therapy, highlighting the need for device therapies targeting mechanisms beyond pharmacological control.
Answers are grounded in this paper and cite their sources.
Cardiovascular implantable electronic devices, including CRT, ICDs, and CCM, are essential complementary therapies to medical management for improving survival and quality of life in chronic heart failure.
Cardiovascular implantable electronic devices (CIEDs) are essential in the management of chronic heart failure, which remains a major cause of morbidity and mortality despite guideline-directed medical therapy. By targeting mechanisms beyond pharmacological control, CIEDs improve outcomes through resynchronization, arrhythmia prevention, and contractility modulation. Cardiac resynchronization therapy enhances ventricular synchrony, with conduction system pacing emerging as a physiological alternative to biventricular pacing. Implantable cardioverter-defibrillators remain central to the prevention of sudden cardiac death, while sub-cutaneous implantable cardioverter-defibrillators extend options for patients with limited venous access or an elevated infection risk. Cardiac contractility modulation represents an innovative approach for moderate ventricular dysfunction, augmenting contractility without inducing arrhythmias. Collectively, these therapies complement medical treatment and highlight the importance of individualized, patient-centered strategies to improve survival, functional capacity, and quality of life in patients with heart failure, underscoring the expanding clinical relevance of CIEDs.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) conducted a review in Chronic Heart Failure. Cardiovascular implantable electronic devices (CIEDs) was evaluated. Cardiovascular implantable electronic devices complement medical treatment to improve survival, functional capacity, and quality of life in patients with chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: